| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 6, 2007
Accepted on June 13, 2008
Department of Pharmacology, National Research Institute for Child Health and Development (K.N., Y.F., R.M., A.S., N.M., M.H., J.Y., A.T.), 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan; Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University Faculty of Pharmaceutical Sciences, Kyoto University (G.T.), Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan; and Otsuka Pharmaceutical Co., Ltd. (T.Y., S.N., T.M.), 463-10 Kagasuno, Kawauchi-cho Tokushima 771-0192, Japan
* To whom correspondence should be addressed. E-mail: atanoue{at}nch.go.jp.
Oxytocin (OT) is one of the secretagogues for stress-induced adrenocorticotropoic hormone (ACTH) release. OT-induced ACTH release is reported to be mediated by the vasopressin V1b receptor in the rat pituitary gland, which contains both OT and V1b receptors. We examined OT-induced ACTH release using primary cultures of anterior pituitary cells from wild-type (V1bR+/+) and V1b receptor knockout (V1bR-/-) mice. OT stimulated similar levels of ACTH release from pituitary cells of V1bR+/+ and V1bR-/- mice. OT-induced ACTH release was significantly inhibited by the selective V1b receptor antagonist SSR149415 and by the OT receptor antagonist CL-14–26 in V1bR+/+ mice. In addition, co-treatment with SSR149415 at 10-6 M and CL-14–26 at 10-6 M inhibited OT-induced ACTH release to the control level in V1bR+/+ mice. In V1bR-/- mice, OT-induced ACTH release was significantly inhibited by CL-14–26 at 10-8 M and completely inhibited at 10-7 M. These results indicate that OT induces the ACTH response via OT and V1b receptors in V1bR+/+ mice but via only OT receptors in V1bR-/- mice. The gene expression level of the OT receptor was significantly higher in the anterior pituitary gland of V1bR-/- mice than in that of V1bR+/+ mice, suggesting that the OT receptor is up-regulated to compensate for ACTH release under conditions of V1b receptor deficiency.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |